Financials
- Financial year
- 2025
- Total assets
- €811,436
- Profit
- €82,128
- Solvency
- 30.1%
Total assets▼ 5.7%
Net result
20182025
Summary
B&B PHARMA has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €244,361 and a net result of €82,128. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 43% of 12,519 sector peers (NACE 47, financial year 2025). The company has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€811,436total assets 2025
- Equity
- €244,361
- Profit
- €82,128
Financial health
Holding: outside the score modelBankruptcy probability: sector outside the model
Structure
- Holdings
- 1
- BALTHAZAR EmmanuelDirector
- BOULAL NassimaDirector
Accounts filed 66 days late1 of 6 deeds read
SignalsneutralFiled after the deadlineShow the evidence
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Bankruptcy probability, 12 months
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
1 signal.
neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-10-2026, 66 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
66 days late
2024
19 days late
2023
29 days late
2022
6 days late
2021
18 days early
2020
29 days early
2019
24 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 7 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 August (4 of the last 5 filed years within 37 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
17-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Reappointments: BALTHAZAR Emmanuel (director) and BOULAL…Registered-office move · Amendment of…
- Annual accounts filedfinancial year 2024 · full…
Key points
By topic
Board & ownership
- Board
- 2 members
- BALTHAZAR EmmanuelDirector
- BOULAL NassimaDirector
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 17
- Since
- 2016
- Next accounts
- by 31-07-2027
- 29-08-2024Annual accounts filed
- 31-12-2023Highest result from 2018 to 2025
- 31-12-2023Liquidity more than 5 times
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 02-07-2014
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 28
- Annual meeting
- Second Wednesday of June at 19:00
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What were this company's board, registered office and name on a given date?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.